Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phenylurea Compounds | 1 | 2022 | 529 | 0.640 |
Why?
|
Quinolines | 1 | 2022 | 764 | 0.550 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 6 | 2024 | 5315 | 0.480 |
Why?
|
Immunoconjugates | 1 | 2022 | 954 | 0.470 |
Why?
|
MART-1 Antigen | 1 | 2013 | 65 | 0.440 |
Why?
|
Melanoma-Specific Antigens | 1 | 2013 | 74 | 0.440 |
Why?
|
Cell Count | 2 | 2014 | 1835 | 0.430 |
Why?
|
S100 Proteins | 1 | 2013 | 218 | 0.420 |
Why?
|
Lung Neoplasms | 7 | 2024 | 13380 | 0.320 |
Why?
|
Carcinoma, Renal Cell | 1 | 2022 | 3164 | 0.280 |
Why?
|
Kidney Neoplasms | 1 | 2022 | 4249 | 0.250 |
Why?
|
Colonic Neoplasms | 2 | 2014 | 2538 | 0.250 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9280 | 0.220 |
Why?
|
DNA | 1 | 2014 | 7212 | 0.170 |
Why?
|
Quinazolinones | 1 | 2021 | 221 | 0.170 |
Why?
|
Adenocarcinoma | 2 | 2014 | 6346 | 0.170 |
Why?
|
Mutagenesis, Insertional | 1 | 2021 | 656 | 0.160 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2022 | 664 | 0.160 |
Why?
|
Camptothecin | 1 | 2022 | 591 | 0.160 |
Why?
|
Observer Variation | 2 | 2014 | 2606 | 0.150 |
Why?
|
Mutation | 4 | 2021 | 30052 | 0.140 |
Why?
|
Exons | 1 | 2021 | 2391 | 0.130 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2020 | 423 | 0.130 |
Why?
|
Drug Approval | 1 | 2022 | 814 | 0.120 |
Why?
|
Melanoma | 1 | 2013 | 5709 | 0.120 |
Why?
|
gp100 Melanoma Antigen | 1 | 2013 | 38 | 0.110 |
Why?
|
Skin Neoplasms | 1 | 2013 | 5821 | 0.110 |
Why?
|
Automation, Laboratory | 1 | 2014 | 102 | 0.110 |
Why?
|
Angiogenesis Inhibitors | 1 | 2022 | 2047 | 0.100 |
Why?
|
Melanins | 1 | 2013 | 290 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3492 | 0.090 |
Why?
|
Genes, ras | 1 | 2013 | 654 | 0.090 |
Why?
|
Reference Standards | 1 | 2014 | 1003 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2825 | 0.090 |
Why?
|
Blood Glucose | 1 | 2024 | 6391 | 0.090 |
Why?
|
Laboratories | 1 | 2013 | 458 | 0.090 |
Why?
|
Pathology, Clinical | 1 | 2013 | 376 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5671 | 0.080 |
Why?
|
ras Proteins | 1 | 2013 | 1054 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2014 | 1265 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1745 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4026 | 0.060 |
Why?
|
Neoplasms | 1 | 2013 | 22170 | 0.060 |
Why?
|
Data Collection | 1 | 2013 | 3322 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6484 | 0.050 |
Why?
|
Societies, Medical | 1 | 2013 | 3905 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4511 | 0.050 |
Why?
|
Humans | 11 | 2024 | 761504 | 0.050 |
Why?
|
Carbazoles | 1 | 2022 | 220 | 0.050 |
Why?
|
United States | 2 | 2022 | 72334 | 0.040 |
Why?
|
Software | 1 | 2014 | 4434 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11076 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2014 | 11528 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1834 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8547 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1626 | 0.030 |
Why?
|
Piperidines | 1 | 2022 | 1656 | 0.030 |
Why?
|
Algorithms | 1 | 2014 | 14031 | 0.030 |
Why?
|
Medical Oncology | 1 | 2024 | 2321 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2827 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2013 | 58976 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 220895 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 13446 | 0.020 |
Why?
|
Prospective Studies | 1 | 2013 | 54425 | 0.020 |
Why?
|
Aged | 3 | 2024 | 169289 | 0.020 |
Why?
|
Prognosis | 2 | 2024 | 29625 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15601 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11121 | 0.020 |
Why?
|
Young Adult | 1 | 2013 | 59243 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8002 | 0.020 |
Why?
|
Female | 4 | 2024 | 392644 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2645 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5035 | 0.010 |
Why?
|
Male | 3 | 2024 | 360804 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4111 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18252 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 12947 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13367 | 0.010 |
Why?
|
Adult | 2 | 2013 | 221177 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12148 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 12990 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 80636 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81525 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168459 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 41487 | 0.000 |
Why?
|
Concepts
(85)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_